"N Engl J Med"[journal] 检索结果

481. Case 13-2025: A 70-Year-Old Man with Weight Loss, Weakness, and Anorexia.

作者: Matthew G Gartland.;Samuel C D Cartmell.;John S Albin.;Daniel Restrepo.;Anthony R Russo.
来源: N Engl J Med. 2025年392卷18期1847-1856页

482. Sea Anemone Sting.

作者: Weniko Caré.;Raphaële Mestiri.
来源: N Engl J Med. 2025年392卷18期e43页

483. Chemical Complexity of Food and Implications for Therapeutics.

作者: Giulia Menichetti.;Albert-László Barabási.;Joseph Loscalzo.
来源: N Engl J Med. 2025年392卷18期1836-1845页

484. Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.

作者: Jakub Svoboda.;Daniel J Landsburg.;James Gerson.;Sunita D Nasta.;Stefan K Barta.;Elise A Chong.;Michael Cook.;Noelle V Frey.;Joanne Shea.;Amanda Cervini.;Amy Marshall.;Megan Four.;Megan M Davis.;Julie K Jadlowsky.;Anne Chew.;Edward Pequignot.;Vanessa Gonzalez.;Julia Han Noll.;Luca Paruzzo.;Juliana Rojas-Levine.;Gabriela Plesa.;John Scholler.;Donald L Siegel.;Bruce L Levine.;David L Porter.;Saba Ghassemi.;Marco Ruella.;Andrew Rech.;Rachel M Leskowitz.;Joseph A Fraietta.;Wei-Ting Hwang.;Elizabeth Hexner.;Stephen J Schuster.;Carl H June.
来源: N Engl J Med. 2025年392卷18期1824-1835页

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced (armored) CAR T-cell product (huCART19-IL18) that secretes interleukin-18 to enhance antitumor activity.

485. BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection.

作者: Alexander C Schmidt.;Lee Fairlie.;Elizabeth Hellström.;Angelique Luabeya Kany Kany.;Keren Middelkoop.;Kogieleum Naidoo.;Gonasagrie Nair.;Anele Gela.;Elisa Nemes.;Thomas J Scriba.;Amy Cinar.;Nicole Frahm.;Robin Mogg.;David Kaufman.;Michael W Dunne.;Mark Hatherill.; .
来源: N Engl J Med. 2025年392卷18期1789-1800页

In a previous phase 2 trial, bacille Calmette-Guérin (BCG) revaccination was not shown to provide protection from primary Mycobacterium tuberculosis infection but prevented sustained M. tuberculosis infection, defined by an initial conversion on a QuantiFERON-TB (QFT) test (an interferon-γ release assay) from negative to positive, followed by two additional positive QFT tests at 3 and 6 months after the initial conversion (a secondary end point). A vaccine efficacy of 45% (95% confidence interval [CI], 6 to 68) was observed.

486. Central Nervous System Tuberculomas.

作者: In-Suk Bae.;Yung Ki Park.
来源: N Engl J Med. 2025年392卷18期1846页

487. The Last Dose.

作者: David N Korones.
来源: N Engl J Med. 2025年392卷18期1774-1775页

488. Death by a Thousand Cuts - The Crushing Weight of Nonclinical Demands in Primary Care.

作者: Bruce E Landon.;Sara B Fazio.;Jennifer L Cluett.;Eileen E Reynolds.;Jennifer Potter.
来源: N Engl J Med. 2025年392卷18期1771-1773页

489. The Physiology of Hunger. Reply.

作者: Alessio Fasano.
来源: N Engl J Med. 2025年392卷17期1768页

490. The Physiology of Hunger.

作者: Jens Lund.;Thorkild I A Sørensen.;Mark I Friedman.
来源: N Engl J Med. 2025年392卷17期1767-1768页

491. The Physiology of Hunger.

作者: Sergio Loss.;Joel Stefani.;Luciana Viana.
来源: N Engl J Med. 2025年392卷17期1767页

492. The Physiology of Hunger.

作者: Hakim Rahmoune.;Nada Boutrid.
来源: N Engl J Med. 2025年392卷17期1766-1767页

493. Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A. Reply.

作者: Alok Srivastava.;Trent Spencer.
来源: N Engl J Med. 2025年392卷17期1766页

494. Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A.

作者: Kaili Zhang.
来源: N Engl J Med. 2025年392卷17期1765-1766页

495. Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A.

作者: Madhusudana Girija Sanal.;Ankur Jindal.
来源: N Engl J Med. 2025年392卷17期1765页

496. Initial Intraosseous or Intravenous Access for Out-of-Hospital Cardiac Arrest. Reply.

作者: Mikael F Vallentin.;Asger Granfeldt.;Lars W Andersen.
来源: N Engl J Med. 2025年392卷17期1764页

497. Initial Intraosseous or Intravenous Access for Out-of-Hospital Cardiac Arrest. Reply.

作者: Keith Couper.;Rachael T Fothergill.;Gavin D Perkins.
来源: N Engl J Med. 2025年392卷17期1763-1764页

498. Initial Intraosseous or Intravenous Access for Out-of-Hospital Cardiac Arrest.

作者: Hans van Schuppen.;Patrick Schober.
来源: N Engl J Med. 2025年392卷17期1763页

499. Initial Intraosseous or Intravenous Access for Out-of-Hospital Cardiac Arrest.

作者: Joshua R Lupton.;Jonathan Jui.;Mohamad R Daya.
来源: N Engl J Med. 2025年392卷17期1763页

500. Glofitamab with Polatuzumab Vedotin in Refractory Burkitt's Lymphoma.

作者: Anca Prica.;Mark Roschewski.;Peter Beale.;Stefania Pittaluga.;Jan Delabie.;Claudia Ortega.;Robert Kridel.
来源: N Engl J Med. 2025年392卷17期1760-1762页

结果排序

文献格式

出版时间

出版类型

出版语言